Omnicell OMCL Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $290.97M+15.9% | $251.03M+11.3% | $225.46M-47.8% | $431.5M+4.1% | $414.4M+4.0% | ||
| $99.2M-1.7% | $100.91M-6.1% | $107.43M+1.6% | $105.78M+16.1% | $91.14M+2.8% | ||
| $722.3M+6.2% | $680.07M+3.1% | $659.62M-21.9% | $844.78M+0.6% | $839.67M+3.0% | ||
| $121.5M+1.2% | $120.11M+0.4% | $119.61M+0.6% | $118.95M+2.7% | $115.79M+2.7% | ||
| $737.29M-0.1% | $737.95M0.0% | $737.87M-0.1% | $738.49M+0.3% | $735.96M+0.2% | ||
| $165.43M-2.7% | $170.11M-1.1% | $172.04M-3.0% | $177.35M-2.9% | $182.55M-3.0% | ||
| $2B+1.5% | $1.97B+1.3% | $1.95B-9.2% | $2.15B-0.3% | $2.15B+1.4% | ||
| $58.34M+32.6% | $43.99M-29.6% | $62.49M+0.1% | $62.41M+17.2% | $53.27M+2.9% | ||
| $211.89M+23.3% | $171.86M-3.9% | $178.78M+16.4% | $153.6M-4.0% | $160M+13.2% | ||
| $483.05M+1.4% | $476.61M+4.4% | $456.59M-23.2% | $594.39M-2.2% | $607.53M+2.0% | ||
| $747.48M+0.6% | $742.91M+2.1% | $727.7M-17.5% | $881.88M-1.4% | $894.37M+1.9% | ||
| 100M0.0% | 100M0.0% | 100M0.0% | 100M0.0% | 100M+175,339% | ||
| $396.3M+3.0% | $384.94M-0.5% | $386.97M+1.4% | $381.5M+1.5% | $375.87M-1.8% | ||
| $1.26B+2.0% | $1.23B+0.9% | $1.22B-3.4% | $1.26B+0.5% | $1.26B+1.1% | ||
| $2B+1.5% | $1.97B+1.3% | $1.95B-9.2% | $2.15B-0.3% | $2.15B+1.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Omnicell cover its short-term obligations?
- Its current ratio is 1.50 — current assets exceed current liabilities.
- Where does Omnicell's balance sheet data come from?
- Every line is extracted from Omnicell's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.